{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Who are in the management team of C4 Therapeutics, Inc.?
As of March 2022, the management team of C4 Therapeutics, Inc. includes Executive Chairman and Co-Founder Marc Cohen, President and CEO Andrew Hirsch, and Co-Founder and Director Ken Anderson.
What does C4 Therapeutics, Inc. do?
C4 Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies that target and eliminate disease-causing proteins, primarily in cancer and neurodegenerative diseases. As of March 2025, it has a market cap of $105.80 million, with net sales of $7 million and a net loss of $26 million.
How big is C4 Therapeutics, Inc.?
As of Jun 18, C4 Therapeutics, Inc. has a market capitalization of 105.80 million and reported net sales of 39.79 million with a net profit loss of 103.28 million for the latest four quarters ending in March 2025.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
